Harvard Bioscience of Holliston has acquired HEKA Electronik, a privately held, Germany-based biomedical instrumentation and software business. The acquisition was for approximately $6 million in cash, Harvard Bioscience announced Thursday.
Harvard Bioscience makes life sciences equipment and instruments. Its statement said that HEKA, as a key developer of patch clamp amplifier instruments for biomedical research, “substantially bolsters Harvard Bioscience’s product portfolio in the electrophysiology market. “
Harvard Bioscience said the acquisition is expected to add $4 million to $5 million to its revenue in 2015.
“The acquisition of HEKA builds on our acquisitions of Multi Channel Systems MCS GmbH and Triangle BioSystems, Inc.,” which were completed in October. “It will allow us to expand our presence and become one of the top leaders in the global electrophysiology market,” said Jeffrey A. Duchemin, CEO and president of Harvard Bioscience.
